CDC Lowers Age for Pneumococcal Vaccination from 65 to 50
Lowering the age gives more adults the opportunity to protect themselves from pneumococcal disease at an age when the risk of infection increases, according to the CDC.
Tag: Pneumococcus
All
Latest
CDC Lowers Age for Pneumococcal Vaccination from 65 to 50
Lowering the age gives more adults the opportunity to protect themselves from pneumococcal disease at an age when the risk of infection increases, according to the CDC.
Read More
FDA Approves Merck’s Pneumococcal Vaccine for Adults
The vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults 50 years of age and older.
Read More
FDA Grants Priority Review to Merck’s Pneumococcal Conjugate Vaccine for Adults
The FDA accepted for priority review a new Biologics License Application for V116, Merck’s investigational 21-valent pneumococcal conjugate vaccine designed to help prevent invasive pneumococcal disease and pneumococcal pneumonia in adults.
Read More
CDC Update on Pneumonia
The Centers for Disease Control and Prevention has updated its website on Pneumonia, including updated statistics, risk factors and vaccine information.
Read More
Common Vaccines May Shield Against Alzheimer’s Disease
A year after discovering that flu vaccines decrease the risk of Alzheimer’s disease by 40%, the same research team found that several other common vaccines also provide protective benefits.
Read More
FDA Approves Vaxneuvance Pneumococcal Vaccine for Infants, Children
The FDA has expanded the approval for Merck’s Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
Read More
Pfizer COVID-19 and Pneumococcal Vaccines Safe to Co-administer
Pfizer’s Prevnar 20 pneumococcal vaccine can be safely co-administered with the Pfizer-BioNTech COVID-19 vaccine, according to a Phase 3 study.
Read More
FDA Approves Prevnar 20 Pneumoccocal Vaccine
The US FDA has approved Pfizer’s Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia in adults age 18 and older.
Read More
Study: Dual Influenza and Streptococcus Pneumonia Infection
New research offers an explanation for how influenza A infection, followed by S. pneumoniae infection, causes severe pneumonia and a high death rate.
Read More
Influenza-like Illness Leads to Worsening of Pneumococcal Colonization
New research has found that influenza-like illness can lead to pneumococcal colonization of airways that may persist after recovery.
Read More
Scientists Sequence Genome of Measles Virus in 100-Year-Old Lung
The Atlantic reported that the lung specimen, taken from a girl who died of pneumonia after a measles infection in 1912, had been sitting in the basement of the Berlin Museum of Medical History at the Charité.
Read More
A Young Person’s Death Prompts Questions About Risks of Pneumonia
A 34-year-old ESPN reporter is dead after battling pneumonia, according to several news reports.
Read MoreBacteria in Pneumonia Attack Using Bleaching Agent
Microbes that invade the human body use hydrogen peroxide to weaken the immune system and cause pneumonia, according to new research published in Nature Communications. “By using hydrogen peroxide to defeat the...
Read MoreInvestigating the Role of Nasal Flora and Viral Infection on Acquisition of Pneumococcus
Identification of specific microbiota constellations which appear to control viral and bacterial acquisition might help develop new therapeutic strategies for respiratory infections.
Read More